GSA Capital Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-39,093
| Closed | -$2.81M | – | 1816 |
|
|
2026
Q1 | $2.81M | Buy |
+39,093
| New | +$3.01M | 0.17% | 77 |
|
|
2025
Q1 | – | Sell |
-10,009
| Closed | -$449K | – | 1738 |
|
|
2024
Q4 | $449K | Sell |
10,009
-2,976
| -23% | -$167K | 0.03% | 973 |
|
|
2024
Q3 | $816K | Buy |
+12,985
| New | +$758K | 0.06% | 597 |
|
|
2024
Q2 | – | Sell |
-6,723
| Closed | -$536K | – | 1696 |
|
|
2024
Q1 | $536K | Buy |
+6,723
| New | +$514K | 0.04% | 836 |
|
|
2023
Q4 | – | Sell |
-17,747
| Closed | -$1.24M | – | 1565 |
|
|
2023
Q3 | $1.24M | Buy |
+17,747
| New | +$1.26M | 0.11% | 297 |
|
|
2023
Q2 | – | Sell |
-10,281
| Closed | -$764K | – | 1587 |
|
|
2023
Q1 | $764K | Buy |
+10,281
| New | +$862K | 0.08% | 468 |
|
|
2022
Q3 | – | Sell |
-6,415
| Closed | -$594K | – | 1580 |
|
|
2022
Q2 | $594K | Sell |
6,415
-1,156
| -15% | -$113K | 0.09% | 387 |
|
|
2022
Q1 | $766K | Sell |
7,571
-422
| -5% | -$44.3K | 0.1% | 295 |
|
|
2021
Q4 | $825K | Buy |
+7,993
| New | +$739K | 0.1% | 302 |
|
|
2021
Q1 | – | Sell |
-3,283
| Closed | -$224K | – | 1172 |
|
|
2020
Q4 | $224K | Buy |
+3,283
| New | +$214K | 0.04% | 915 |
|
|
2020
Q2 | – | Sell |
-9,568
| Closed | -$568K | – | 703 |
|
|
2020
Q1 | $568K | Buy |
+9,568
| New | +$639K | 0.14% | 117 |
|
|
2019
Q2 | – | Sell |
-29,583
| Closed | -$1.59M | – | 1489 |
|
|
2019
Q1 | $1.59M | Buy |
29,583
+16,195
| +121% | +$1,000K | 0.16% | 111 |
|
|
2018
Q4 | $877K | Sell |
13,388
-14,364
| -52% | -$1.07M | 0.1% | 274 |
|
|
2018
Q3 | $2.19M | Buy |
+27,752
| New | +$1.98M | 0.12% | 202 |
|
|
2018
Q2 | – | Sell |
-48,375
| Closed | -$3.01M | – | 1723 |
|
|
2018
Q1 | $3.01M | Buy |
48,375
+41,849
| +641% | +$3M | 0.16% | 116 |
|
|
2017
Q4 | $473K | Buy |
+6,526
| New | +$474K | 0.03% | 964 |
|
|
2017
Q2 | – | Sell |
-6,751
| Closed | -$530K | – | 1722 |
|
|
2017
Q1 | $530K | Buy |
+6,751
| New | +$539K | 0.03% | 1064 |
|
|
2016
Q4 | – | Sell |
-30,323
| Closed | -$2.7M | – | 1789 |
|
|
2016
Q3 | $2.7M | Buy |
30,323
+16,551
| +120% | +$1.56M | 0.15% | 140 |
|
|
2016
Q2 | $1.32M | Buy |
+13,772
| New | +$1.37M | 0.07% | 461 |
|
|
2016
Q1 | – | Sell |
-31,059
| Closed | -$3.04M | – | 1715 |
|
|
2015
Q4 | $3.04M | Sell |
31,059
-34,535
| -53% | -$3.38M | 0.15% | 118 |
|
|
2015
Q3 | $6.33M | Buy |
+65,594
| New | +$6.9M | 0.31% | 28 |
|
|
2015
Q2 | – | Sell |
-37,626
| Closed | -$3.88M | – | 1975 |
|
|
2015
Q1 | $3.88M | Buy |
37,626
+12,772
| +51% | +$1.29M | 0.15% | 92 |
|
|
2014
Q4 | $2.39M | Sell |
24,854
-14,450
| -37% | -$1.27M | 0.17% | 102 |
|
|
2014
Q3 | $3.13M | Sell |
39,304
-78,870
| -67% | -$6.22M | 0.16% | 118 |
|
|
2014
Q2 | $8.91M | Buy |
+118,174
| New | +$8.93M | 0.4% | 22 |
|
|
2013
Q4 | – | Sell |
-217,419
| Closed | -$12.3M | – | 1646 |
|
|
2013
Q3 | $12.3M | Buy |
217,419
+204,598
| +1,596% | +$12.2M | 0.98% | 1 |
|
|
2013
Q2 | $733K | Buy |
+12,821
| New | +$743K | 0.09% | 346 |
|
Other funds holding CVS
GSA Capital Partners's CVS Position: Q2 2026 in Review
GSA Capital Partners sold out of CVS Health (CVS) in Q2 2026, closing a stake of 39,093 shares — an estimated $2.81M sold.
GSA Capital Partners first reported a position in CVS in Q2 2013 and held it in 27 quarters. The position peaked at $12.3M in Q3 2013. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- GSA Capital Partners reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
- GSA Capital Partners sold 39,093 CVS Health shares in Q2 2026, an estimated $2.81M.
- GSA Capital Partners first reported a position in CVS Health in Q2 2013 and held it in 27 quarters.
- GSA Capital Partners's CVS Health position peaked at $12.3M in Q3 2013.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.